Stay updated on Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. There are no user-visible changes to the study details or layout.
    Difference
    0.0%
    Check dated 2026-03-11T14:44:16.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added site revision note Revision: v3.4.2. Removed the government funding lapse notice and the previous Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T09:18:19.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    - Added a site-wide notice about a lapse in government funding and updated operating status. - Updated the site version from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:17:04.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a glossary toggle display and updated footer metadata including Last Update Posted, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Some labels were adjusted for capitalization (No FEAR Act data).
    Difference
    0.2%
    Check dated 2026-01-28T02:44:19.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, indicating a minor administrative update. The trial details and content appear unchanged.
    Difference
    0.0%
    Check dated 2026-01-14T02:26:11.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added a centralized Locations section listing study sites by state/province (Alabama, Arizona, California, Colorado, Florida, Illinois, Kentucky, Maryland, Massachusetts, Minnesota, Missouri, North Carolina, Pennsylvania, Texas, Utah) and Ontario. Removed the scattered per-state 'X Locations' blocks and consolidated site information for easier enrollment lookup.
    Difference
    1%
    Check dated 2025-12-23T14:32:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.